432 related articles for article (PubMed ID: 9034168)
1. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins.
Bork P; Hofmann K; Bucher P; Neuwald AF; Altschul SF; Koonin EV
FASEB J; 1997 Jan; 11(1):68-76. PubMed ID: 9034168
[TBL] [Abstract][Full Text] [Related]
2. Boundaries and physical characterization of a new domain shared between mammalian 53BP1 and yeast Rad9 checkpoint proteins.
Alpha-Bazin B; Lorphelin A; Nozerand N; Charier G; Marchetti C; Bérenguer F; Couprie J; Gilquin B; Zinn-Justin S; Quéméneur E
Protein Sci; 2005 Jul; 14(7):1827-39. PubMed ID: 15987907
[TBL] [Abstract][Full Text] [Related]
3. The BRCT domain is a phospho-protein binding domain.
Yu X; Chini CC; He M; Mer G; Chen J
Science; 2003 Oct; 302(5645):639-42. PubMed ID: 14576433
[TBL] [Abstract][Full Text] [Related]
4. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair.
Callebaut I; Mornon JP
FEBS Lett; 1997 Jan; 400(1):25-30. PubMed ID: 9000507
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for phosphorylation-dependent signaling in the DNA-damage response.
Williams RS; Bernstein N; Lee MS; Rakovszky ML; Cui D; Green R; Weinfeld M; Glover JN
Biochem Cell Biol; 2005 Dec; 83(6):721-7. PubMed ID: 16333323
[TBL] [Abstract][Full Text] [Related]
6. Structure of an XRCC1 BRCT domain: a new protein-protein interaction module.
Zhang X; Moréra S; Bates PA; Whitehead PC; Coffer AI; Hainbucher K; Nash RA; Sternberg MJ; Lindahl T; Freemont PS
EMBO J; 1998 Nov; 17(21):6404-11. PubMed ID: 9799248
[TBL] [Abstract][Full Text] [Related]
7. Cancer predisposing mutations in BRCT domains.
di Masi A; Gullotta F; Cappadonna V; Leboffe L; Ascenzi P
IUBMB Life; 2011 Jul; 63(7):503-12. PubMed ID: 21698754
[TBL] [Abstract][Full Text] [Related]
8. The BRCA1 C-terminal domain: structure and function.
Huyton T; Bates PA; Zhang X; Sternberg MJ; Freemont PS
Mutat Res; 2000 Aug; 460(3-4):319-32. PubMed ID: 10946236
[TBL] [Abstract][Full Text] [Related]
9. Rho exchange factor ECT2 is induced by growth factors and regulates cytokinesis through the N-terminal cell cycle regulator-related domains.
Saito S; Tatsumoto T; Lorenzi MV; Chedid M; Kapoor V; Sakata H; Rubin J; Miki T
J Cell Biochem; 2003 Nov; 90(4):819-36. PubMed ID: 14587037
[TBL] [Abstract][Full Text] [Related]
10. Retinoblastoma susceptibility protein, Rb, possesses multiple BRCT-Ws, BRCA1 carboxyl-terminus-related W regions with DNA break-binding activity.
Yamane K; Katayama E; Sugasawa K; Tsuruo T
Oncogene; 2000 Apr; 19(16):1982-91. PubMed ID: 10803459
[TBL] [Abstract][Full Text] [Related]
11. p53 contains a DNA break-binding motif similar to the functional part of BRCT-related region of Rb.
Yamane K; Katayama E; Tsuruo T
Oncogene; 2001 May; 20(23):2859-67. PubMed ID: 11420698
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
Williams RS; Green R; Glover JN
Nat Struct Biol; 2001 Oct; 8(10):838-42. PubMed ID: 11573086
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the interaction between the human DNA topoisomerase IIbeta-binding protein 1 (TopBP1) and the cell division cycle 45 (Cdc45) protein.
Schmidt U; Wollmann Y; Franke C; Grosse F; Saluz HP; Hänel F
Biochem J; 2008 Jan; 409(1):169-77. PubMed ID: 17887956
[TBL] [Abstract][Full Text] [Related]
14. BRCT repeats as phosphopeptide-binding modules involved in protein targeting.
Manke IA; Lowery DM; Nguyen A; Yaffe MB
Science; 2003 Oct; 302(5645):636-9. PubMed ID: 14576432
[TBL] [Abstract][Full Text] [Related]
15. Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1.
Gaiser OJ; Ball LJ; Schmieder P; Leitner D; Strauss H; Wahl M; Kühne R; Oschkinat H; Heinemann U
Biochemistry; 2004 Dec; 43(51):15983-95. PubMed ID: 15609993
[TBL] [Abstract][Full Text] [Related]
16. TopBP1 contains a transcriptional activation domain suppressed by two adjacent BRCT domains.
Wright RH; Dornan ES; Donaldson MM; Morgan IM
Biochem J; 2006 Dec; 400(3):573-82. PubMed ID: 16984230
[TBL] [Abstract][Full Text] [Related]
17. The BRCT regions of tumor suppressor BRCA1 and of XRCC1 show DNA end binding activity with a multimerizing feature.
Yamane K; Katayama E; Tsuruo T
Biochem Biophys Res Commun; 2000 Dec; 279(2):678-84. PubMed ID: 11118345
[TBL] [Abstract][Full Text] [Related]
18. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure.
Joo WS; Jeffrey PD; Cantor SB; Finnin MS; Livingston DM; Pavletich NP
Genes Dev; 2002 Mar; 16(5):583-93. PubMed ID: 11877378
[TBL] [Abstract][Full Text] [Related]
19. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
Rodriguez M; Yu X; Chen J; Songyang Z
J Biol Chem; 2003 Dec; 278(52):52914-8. PubMed ID: 14578343
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of ATR-interacting protein on Ser239 mediates an interaction with breast-ovarian cancer susceptibility 1 and checkpoint function.
Venere M; Snyder A; Zgheib O; Halazonetis TD
Cancer Res; 2007 Jul; 67(13):6100-5. PubMed ID: 17616665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
